CLINICAL_TRIALS
trial_result
· 2024-06-25
Clinical Trial Update: Study of Poziotinib in Japanese Patients With NSCLC [Phase 1, Phase 2]
Summary
A Phase 1/2 trial of Poziotinib in Japanese patients with non-small cell lung cancer was terminated, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Spectrum Pharmaceuticals, Inc | Conditions: NSCLC | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-06-25